Navigation Links
Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
Date:11/16/2011

WASHINGTON, Nov. 16, 2011 /PRNewswire-USNewswire/ --

Livestream Info

Watch it live: Thursday at 8:15 a.m.
http://thehill.com/video/in-the-news/193083-livestreaming-genetic-testing-briefing.

Twitter:  #genetestbriefing.

American innovation in genetic testing is redefining cancer treatment, and the pace of discovery promises new cancer-fighting therapies across a range of cancer types and conditions. That will be among the topics of discussion today at The Hill's policy briefing, "The Innovation Revolution:  Genetic Testing in Today's Cancer Care."

The briefing will take place from 8:30 a.m. to 10 a.m. in Room 1539 Longworth House Office Building.

Featured speakers include Representatives Michael Burgess, MD, (R-TX) and Charles Gonzalez (D-TX).  Rep. Burgess, a physician himself, serves as vice chair of the House Energy and Commerce Health Subcommittee, and Rep. Gonzalez also is a member of the House Energy and Commerce Health Subcommittee

The Hill's policy briefing, sponsored by the American Clinical Laboratory Association and Results for Life, also features comments by Mara Bloom, Executive Director of Massachusetts General Hospital Cancer Center, and Marc Grodman, MD, Chairman, President and CEO of Bio-Reference Laboratories, on how new genetic tests are being translated into life-saving care for patients. Joining the discussion on genetic testing's influence on recommended clinical treatment guidelines is Bill McGivney, PhD, CEO of the National Comprehensive Cancer Network.

Battelle Memorial Institute Senior Director Simon Tripp will paint a vision of the future of genetic testing and its impact on medical care, job growth, and the economy.

The American Clinical Laboratory Association represents the nation's clinical laboratories. The group's educational campaign, Results for Life, focuses on the value of laboratory medicine.  See www.labresultsforlife.org

For more information contact: Ron Geigle: rongeigle@polidais.com; 202.461.2246; 
or Helen Pettay: helen.pettay@polidais.com; 910.795.1202


'/>"/>
SOURCE American Clinical Laboratory Association
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Campaign for Cancer Prevention Connects 6 Million+ Members on Facebook Causes to Groundbreaking Research at Brigham and Womens Hospital
2. The American Ceramic Society selects Marshall, Niihara as 2011 Distinguish Life Members
3. Elsevier Collaborates with the Wilderness Medicine Society to Award Outstanding Members
4. Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
5. MAC Members Grow Atlantas Bioscience Reputation
6. Online Career Service for Postgraduate Life Scientists Expands Membership to Individuals
7. Thomas, McNerney & Partners Promotes Two Members of its Investment Team
8. IGEN Networks Corp continues to build a world class advisory board, with the appointment of three new members
9. IGEN NETWORKS ANNOUNCES THE APPOINTMENT OF TWO NEW MEMBERS TO THE ADVISORY BOARD
10. IGEN Networks announce the appointment of two new members to the Advisory Board
11. Bacterin International Appoints Three New Members to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in a published evaluation of multiple immunoassay-based threat detection technologies by researchers ... Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have the ...
(Date:2/23/2017)... 23, 2017 Aviva Systems Biology Corporation ... acquisition of GenWay Biotech Incorporated, a protein solutions ... product offering for both the research and diagnostic ... and enhance capabilities for both entities. GenWay,s 18 years ... will nicely complement ASB,s objective to become a ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):